Cargando…
Ex Vivo Expanded Human Non-Cytotoxic CD8(+)CD45RC(low/−) Tregs Efficiently Delay Skin Graft Rejection and GVHD in Humanized Mice
Both CD4(+) and CD8(+) Tregs play a critical role in the control of immune responses and immune tolerance; however, our understanding of CD8(+) Tregs is limited while they are particularly promising for therapeutic application. We report here existence of highly suppressive human CD8(+)CD45RC(low/−)...
Autores principales: | Bézie, Séverine, Meistermann, Dimitri, Boucault, Laetitia, Kilens, Stéphanie, Zoppi, Johanna, Autrusseau, Elodie, Donnart, Audrey, Nerrière-Daguin, Véronique, Bellier-Waast, Frédérique, Charpentier, Eric, Duteille, Franck, David, Laurent, Anegon, Ignacio, Guillonneau, Carole |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797797/ https://www.ncbi.nlm.nih.gov/pubmed/29445370 http://dx.doi.org/10.3389/fimmu.2017.02014 |
Ejemplares similares
-
Genetic engineering of human and mouse CD4(+) and CD8(+) Tregs using lentiviral vectors encoding chimeric antigen receptors
por: Vimond, Nadège, et al.
Publicado: (2020) -
IL-34 Actions on FOXP3(+) Tregs and CD14(+) Monocytes Control Human Graft Rejection
por: Bézie, Séverine, et al.
Publicado: (2020) -
Future prospects for CD8(+) regulatory T cells in immune tolerance
por: Flippe, Léa, et al.
Publicado: (2019) -
Super-Treg: Toward a New Era of Adoptive Treg Therapy Enabled by Genetic Modifications
por: Amini, Leila, et al.
Publicado: (2021) -
Alloantigenic recognition properties of CD8(+) regulatory T cells
por: Picarda, Elodie, et al.
Publicado: (2011)